Core Laboratories N.V.
CLB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $811,787 | $824,422 | $939,190 | $1,026,461 |
| - Cash | $19,157 | $15,120 | $15,428 | $17,703 |
| + Debt | $180,144 | $215,385 | $222,390 | $250,264 |
| Enterprise Value | $972,774 | $1,024,687 | $1,146,152 | $1,259,022 |
| Revenue | $523,848 | $509,790 | $489,735 | $470,252 |
| % Growth | 2.8% | 4.1% | 4.1% | – |
| Gross Profit | $88,373 | $94,049 | $78,919 | $83,840 |
| % Margin | 16.9% | 18.4% | 16.1% | 17.8% |
| EBITDA | $73,273 | $70,424 | $58,685 | $63,778 |
| % Margin | 14% | 13.8% | 12% | 13.6% |
| Net Income | $31,400 | $36,675 | $19,453 | $19,727 |
| % Margin | 6% | 7.2% | 4% | 4.2% |
| EPS Diluted | 0.66 | 0.77 | 0.42 | 0.42 |
| % Growth | -14.3% | 83.3% | 0% | – |
| Operating Cash Flow | $56,388 | $24,789 | $24,956 | $36,579 |
| Capital Expenditures | -$13,028 | -$10,579 | -$10,216 | -$13,539 |
| Free Cash Flow | $43,360 | $14,210 | $14,740 | $23,040 |